Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of Jointstem in knee osteoarthritis
NCT03509025Phase 2Completed
- Sponsor
- R Bio
- Start
- Feb 2017
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of JOINTSTEM in knee osteoarthritis (OA), sponsored by R Bio. Primary endpoint: Adverse Events at 60 months. Started Feb 2017; status: completed.
02
Drugs
JOINTSTEM
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03509025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509025.